Literature DB >> 17182563

IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs.

Yoh-Ichi Seki1, Jianying Yang, Mariko Okamoto, Shinya Tanaka, Ryo Goitsuka, Michael A Farrar, Masato Kubo.   

Abstract

Constitutive expression of suppressors of cytokine signaling (SOCS)1 in T lineage in vivo attenuated cytokine signaling and resulted in a dramatic reduction in the number of naive CD44(low)CD62L(high) CD4 T cells in the spleen. After adoptive transfer of thymocytes from SOCS1 transgenic mice into normal recipients, naive CD4 T cells rapidly disappeared from the spleen within 1 wk. Likewise, T cell-specific deletion of STAT5a/b in vivo resulted in a similar phenotype characterized by loss of naive CD4 T cells. Thus, STAT5-mediated signaling is crucial for promoting naive T cell survival. However, forced expression of constitutively active STAT5 failed to rescue CD4 T cells in SOCS1 transgenic mice, implying that STAT5 activation is necessary but not sufficient for naive CD4 T cell survival. Although blockade of the IL-7R, a SOCS1 target, resulted in clear inhibition of naive T cell survival, the effect occurred 3 wk after anti-IL-7R Ab treatment, but not at earlier time points. These results suggest that IL-7-mediated STAT5 activation is essential for long-term survival of naive CD4 cells after export from thymus, and that another SOCS1-sensitive cytokine is critical for short-term naive T cell survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182563     DOI: 10.4049/jimmunol.178.1.262

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

2.  HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells.

Authors:  Marta Catalfamo; Michele Di Mascio; Zonghui Hu; Sharat Srinivasula; Vishakha Thaker; Joseph Adelsberger; Adam Rupert; Michael Baseler; Yutaka Tagaya; Gregg Roby; Catherine Rehm; Dean Follmann; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

3.  Directed differentiation of induced pluripotent stem cells towards T lymphocytes.

Authors:  Fengyang Lei; Rizwanul Haque; Xiaofang Xiong; Jianxun Song
Journal:  J Vis Exp       Date:  2012-05-14       Impact factor: 1.355

4.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

5.  Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Ana María De Rissio; Miriam Postan
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

6.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

7.  Disparate roles for STAT5 in primary and secondary CTL responses.

Authors:  Diana M Mitchell; Matthew A Williams
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

8.  Cooperation between molecular targets of costimulation in promoting T cell persistence and tumor regression.

Authors:  Baohua Zhao; Aihua Song; Rizwanul Haque; Fengyang Lei; Lauren Weiler; Xiaofang Xiong; Yuzhang Wu; Michael Croft; Jianxun Song
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.

Authors:  Mohammad Haque; Jianyong Song; Kristin Fino; Praneet Sandhu; Youfei Wang; Bing Ni; Deyu Fang; Jianxun Song
Journal:  Cell Transplant       Date:  2016-01-15       Impact factor: 4.064

10.  MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Authors:  Jan C Dudda; Bruno Salaun; Yun Ji; Douglas C Palmer; Gwennaelle C Monnot; Estelle Merck; Caroline Boudousquie; Daniel T Utzschneider; Thelma M Escobar; Rachel Perret; Stefan A Muljo; Michael Hebeisen; Nathalie Rufer; Dietmar Zehn; Alena Donda; Nicholas P Restifo; Werner Held; Luca Gattinoni; Pedro Romero
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.